Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/10/07 → 8/10/10 |
Funding
- Quintiles, Inc. (WA20495 / ACT3986g)
- Genentech, Inc (WA20495 / ACT3986g)
Prot# WA20495 / ACT3986g: A Randomized, Double-Blind, Parallel Group, International Study to Evaluate the Safety and Efficacy of Ocrelizumab Compared to Placebo in Patients with Active Rheumatoid Arthritis who have an Inadequate Response to at Least One A
- Ruderman, Eric M (PD/PI)
Project: Research project